Leo Pharma Launches Delgocitinib Cream (Anzupgo) for CHE in Germany
LEO Pharma is launching delgocitinib cream (Anzupgo) in Germany for the treatment of adult patients with moderate to severe Chronic Hand Eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate. Germany is the first country worldwide where delgocitinib cream will be available, following the recent European Commission (EC) approval. The EC decision means Anzupgo […]